Furthermore, PDGF signaling has been found to play an active role in breast tumor progression and PDGFRB has previously been theorized—along with its cognate ligand PDGFB—to be a potential therapeutic target for multiple human cancers, including breast [68]. The gene discussed is PDGFB; the disease is cancer.